Home
Conditions
Urothelial Carcinoma

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

239 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Not Yet Recruiting

Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor

NCT06551896

Conditions: Breast Diseases, Breast Neoplasms, Carcinoma, +25 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria

NCT06469229

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +23 more
Locations: Changhai Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

NCT04773951

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: Fujian Provincial Cancer Hospital Fuzhou, Fujian, China

Tumor Hospital affiliated to Harbin Medical University Harbin, Heilongjiang, China

Hunan Cancer Hospital Changsha, Hunan, China

Nanjing Drum Tower Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

NCT06339138

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer

NCT02769962

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +23 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

NCT04018053

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Predictive Factorsfor Final Pathologic Ureteral Sections

NCT03677544

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations: CHU Amiens-Picardie Amiens, France

View Trial Details

Completed

A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer

NCT07386847

Conditions: Carcinoma, Carcinoma, Transitional Cell, Locally Advanced or Metastatic Urothelial Carcinoma, +6 more
Locations: Pfizer Office New York, United States

View Trial Details

Completed

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

NCT04902872

Conditions: Adnexal Diseases, Appendiceal Neoplasms, Appendix Cancer, +61 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

NEXT Oncology Austin, Texas, United States

MD Anderson Cancer Center Houston, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Completed

Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response

NCT04146064

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +26 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Urothelial Carcinoma

Urothelial Carcinoma trial results

Related conditions